IFM Investors Pty Ltd grew its stake in shares of Humana Inc (NYSE:HUM) by 48.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,792 shares of the insurance provider’s stock after buying an additional 4,815 shares during the quarter. IFM Investors Pty Ltd’s holdings in Humana were worth $3,782,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the company. Endurance Wealth Management Inc. grew its stake in shares of Humana by 354.5% in the third quarter. Endurance Wealth Management Inc. now owns 100 shares of the insurance provider’s stock worth $26,000 after purchasing an additional 78 shares during the last quarter. Whittier Trust Co. bought a new stake in shares of Humana in the second quarter worth about $27,000. Next Capital Management LLC bought a new stake in shares of Humana in the second quarter worth about $27,000. Quest Capital Management Inc. ADV bought a new stake in shares of Humana in the third quarter worth about $30,000. Finally, Advantage Investment Management LLC grew its stake in shares of Humana by 287.1% in the second quarter. Advantage Investment Management LLC now owns 120 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 89 shares during the last quarter. 92.93% of the stock is currently owned by hedge funds and other institutional investors.
In other Humana news, insider Brian P. Leclaire sold 7,239 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $289.70, for a total value of $2,097,138.30. Following the completion of the sale, the insider now directly owns 12,994 shares in the company, valued at $3,764,361.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.54% of the company’s stock.
HUM has been the topic of several recent analyst reports. Morgan Stanley cut their target price on Humana from $342.00 to $337.00 and set an “overweight” rating on the stock in a research note on Thursday, September 26th. Cantor Fitzgerald raised Humana from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $300.00 to $345.00 in a research note on Monday, August 12th. BMO Capital Markets cut Humana from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $345.00 to $290.00 in a research note on Monday, September 30th. SunTrust Banks raised their target price on Humana to $340.00 and gave the stock a “hold” rating in a research note on Thursday, August 1st. Finally, Deutsche Bank initiated coverage on Humana in a research note on Thursday, September 12th. They issued a “hold” rating and a $300.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and sixteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $333.30.
Shares of HUM opened at $304.94 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.75 and a quick ratio of 1.75. Humana Inc has a one year low of $225.65 and a one year high of $355.88. The company has a 50-day simple moving average of $275.88 and a two-hundred day simple moving average of $270.18. The firm has a market capitalization of $40.12 billion, a PE ratio of 20.96, a price-to-earnings-growth ratio of 1.28 and a beta of 0.85.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, November 6th. The insurance provider reported $5.03 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $4.58 by $0.45. Humana had a net margin of 4.13% and a return on equity of 22.47%. The business had revenue of $16.24 billion during the quarter, compared to analyst estimates of $16.15 billion. During the same period last year, the business posted $4.58 earnings per share. Humana’s quarterly revenue was up 14.3% compared to the same quarter last year. Analysts expect that Humana Inc will post 17.67 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.55 dividend. The ex-dividend date is Monday, December 30th. This represents a $2.20 annualized dividend and a yield of 0.72%. Humana’s dividend payout ratio (DPR) is presently 15.12%.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading: How to calculate compound interest
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.